Kaiser Permanente Center for Health Research, 3800 North Interstate Avenue, Portland, OR 97227, USA.
Ann Intern Med. 2013 Feb 19;158(4):253-60. doi: 10.7326/0003-4819-158-4-201302190-00580.
Interventions to prevent smoking uptake or encourage cessation among young persons might help prevent tobacco-related illness.
To review the evidence for the efficacy and harms of primary care-relevant interventions that aim to reduce tobacco use among children and adolescents.
Three systematic reviews that collectively covered the relevant literature; MEDLINE, PsycINFO, the Cochrane Central Register of Controlled Trials, and the Database of Abstracts of Reviews of Effects through 14 September 2012; and manual searches of reference lists and gray literature.
Two investigators independently reviewed 2453 abstracts and 111 full-text articles. English-language trials of behavior-based or medication interventions that were relevant to primary care and reported tobacco use, health outcomes, or harms were included.
One investigator abstracted data from good- and fair-quality trials into an evidence table, and a second checked these data.
19 trials (4 good-quality and 15 fair-quality) that were designed to prevent tobacco use initiation or promote cessation (or both) and reported self-reported smoking status or harms were included. Pooled analyses from a random-effects meta-analysis suggested a 19% relative reduction (risk ratio, 0.81 [95% CI, 0.70 to 0.93]; absolute risk difference, -0.02 [CI, -0.03 to 0.00]) in smoking initiation among participants in behavior-based prevention interventions compared with control participants. Neither behavior-based nor bupropion cessation interventions improved cessation rates. Findings about the harms related to bupropion use were mixed.
No studies reported health outcomes. Interventions and measures were heterogeneous. Most trials examined only cigarette smoking. The body of evidence was largely published 5 to 15 years ago.
Primary care-relevant interventions may prevent smoking initiation over 12 months in children and adolescents.
干预措施旨在预防年轻人吸烟或鼓励其戒烟,可能有助于预防与烟草相关的疾病。
综述旨在减少儿童和青少年烟草使用的初级保健相关干预措施的有效性和危害。
对截至 2012 年 9 月 14 日的相关文献进行了三项系统综述,共涵盖了文献;MEDLINE、PsycINFO、Cochrane 对照试验中心注册库和效果摘要数据库;并手动检索参考文献和灰色文献。
两名调查员独立审查了 2453 份摘要和 111 篇全文文章。纳入了与初级保健相关且报告了烟草使用、健康结果或危害的基于行为或药物干预的英语试验。
一名调查员将高质量和中等质量试验中的数据摘要到证据表中,第二名调查员检查了这些数据。
纳入了 19 项旨在预防烟草使用开始或促进戒烟(或两者兼有)并报告自我报告吸烟状况或危害的试验(4 项高质量和 15 项中等质量)。一项随机效应荟萃分析的汇总分析表明,与对照组相比,基于行为的预防干预组参与者的吸烟起始率相对降低了 19%(风险比,0.81[95%CI,0.70 至 0.93];绝对风险差异,-0.02[CI,-0.03 至 0.00])。基于行为或安非他酮的戒烟干预措施均未提高戒烟率。关于安非他酮使用相关危害的研究结果参差不齐。
没有研究报告健康结果。干预措施和措施各不相同。大多数试验仅研究了吸烟情况。证据主要来自 5 至 15 年前发表的文献。
初级保健相关干预措施可能会在 12 个月内预防儿童和青少年开始吸烟。